SEARCH

SEARCH BY CITATION

References

  • American Veterinary Medical Association (AVMA). (2001) AVMA Panel on Euthanasia 2000 Report of the AVMA panel on euthanasia. Journal of the American Veterinary Medical Association, 218, 669696.
  • Australian Pesticides and Veterinary Medicines Authority (APVMA). (2012) Maximum residue limits in food and animal feedstuff. Available at: http://www.apvma.gov.au/residues/docs/mrl_table1_december_2012.pdf
  • Beutin, L., Preller, E. & Kowalski, B. (1981) Mutagenicity of quindoxin, its metabolites, and two substituted quinoxaline-di-N-oxides. Antimicrobial agents and chemotherapy, 20, 336343.
  • Bronsch, K., Schneider, D. & Rigal-Antonelli, F. (1976) Olaquindox - a new growth promoter in animal nutrition. 1. Effectiveness in raising piglets. Zeitschrift für Tierphysiologie, Tierernährung und Futtermittelkunde, 36, 211221.
  • Buur, J.L., Baynes, R.E., Craigimill, A.L. & Riviere, J.E. (2005) Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in swine tissue. American journal of veterinary research, 66, 16861693.
  • Buur, J.L., Baynes, R., Smith, G. & Riviere, J.E. (2006) Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrobial agents and chemotherapy, 50, 23442351.
  • Buur, J.L., Baynes, R.E. & Riviere, J.E. (2008) Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model. Regulatory toxicology and pharmacology, 51, 324331.
  • Chen, Q., Tang, S., Jin, X., Zou, J., Chen, K., Zhang, T. & Xiao, X. (2009) Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells. Food and chemical toxicology, 47, 328334.
  • Chiesa, O.A., Von Bredow, J., Smith, M., Heller, D., Condon, R. & Thomas, M.H. (2006a) Bovine kidney tissue/biological fluid correlation for penicillin. Journal of veterinary pharmacology and therapeutics, 29, 299306.
  • Chiesa, O.A., Von Bredow, J., Nochetto, C., Smith, M., Heller, D., Moulton, K. & Thomas, M.H. (2006b) Use of tissue-fluid correlations to estimate gentamicin residues in kidney tissue of Holstein steers. Journal of veterinary pharmacology and therapeutics, 29, 99106.
  • Cihák, R. & Srb, V. (1983) Cytogenetic effects of quinoxaline-1, 4-dioxide-type growth-promoting agents. I. Micronucleus test in rats. Mutation research, 116, 129135.
  • Clewell, H.J., Gentry, P.R., Covington, T.R. & Gearhart, J.M. (2000) Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environmental health perspectives, 108, 283305.
  • Commission Regulation (EC) No. 2788/98. (1998) Off. European Journal of Disorders of Communication, L347, 3.
  • Corley, R.A., Bartels, M.J., Carney, E.W., Weitz, K.K., Soelberg, J.J., Gies, R.A. & Thrall, K.D. (2005) Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic Acid, in rats and humans. Toxicological Sciences, 85, 476490.
  • Cortright, K.A., Wetzlich, S.E. & Craigmill, A.L. (2009) A PBPK model for midazolam in four avian species. Journal Veterinary Pharmacology Therapeutics, 32, 552565.
  • Craigmill, A.L. (2003) A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. Journal Veterinary Pharmacology Therapeutics, 26, 5563.
  • Eberlein, B., Bergner, T. & Przybilla, B. (1992) Demonstration of olaquindox phototoxicity in vitro. Photodermatology, photoimmunology & photomedicine, 9, 6366.
  • Ellis, R.L. (1990) Summary of the evaluation at the 36th meeting of JECFA, 53.
  • Emmert, B., Schauder, S., Palm, H., Hallier, E. & Emmert, S. (2007) Disabling work-related persistent photosensitivity following photoallergic contact dermatitis from chlorpromazine and olaquindox in a pig breeder. Annals of agricultural and environmental medicine, 14, 329333.
  • Holt, J.P., Rhode, E.A. & Kines, H. (1968) Ventricular volumes and body weight in mammals. American Journal of Physiology, 215, 704715.
  • Joint FAO/WHO Expert Committee on Food Additives (JECFA). (1990) Evaluation of Certain Veterinary Drug Residues in Food, pp. 4554. In World Health Organization, Geneva.
  • Joint FAO/WHO Expert Committee on Food Additives (JECFA). (1995) Evaluation of Certain Veterinary Drug Residues in Food, pp. 1921. In World Health Organization, Geneva.
  • Kaemmerer, K. (1990) Studies with olaquindox. 3rd communication. blood level pattern in rats and pigs after oral ingestion. Veterinary medical review, 1, 4058.
  • Leavens, T.L. & Borghoff, S.J. (2009) Physiologically based pharmacokinetic model of methyl tertiary butyl ether and tertiary butyl alcohol dosimetry in male rats based on binding to α2u-globulin. Toxicological sciences, 109, 321335.
  • MacLachlan, D.J. (2010) Physiologically based pharmacokinetic (PBPK) model for residues of lipophilic pesticides in poultry. Food Additives & Contaminants Part A, 27, 302314.
  • Mercer, H.D., Baggot, J.D. & Sams, R.A. (1977) Application of pharmacokinetic methods to the drug residue profile. Journal of Toxicology and Environmental Health, 2, 787801.
  • Ministry of Agriculture Bulletin., PR China No. 168. (2001) Feed additive drug us norms.
  • Ministry of Agriculture Bulletin., PR China No. 235. (2002) The maximum residue limits of veterinary drugs in food of animal origin.
  • Ministry of Health, Labour and Welfare. Provisional MRLs List. (2007), Available at: http://www.mhlw.go.jp/english/topics/foodsafety/positivelist060228/dl/index-1c.pdf
  • Riviere, J.E. (1999) Hepatic Biotransformation and Biliary Excretion. Comparative Pharmacokinetics: Principles, Techniques, and Applications. Blackwell Publishing, Inc., Ames, Iowa, 6, 99–101.
  • Schneider, D., Bronsch, K. & Richter, L. (1976) Olaquindox–a new growth promoting feed additive. II. Effect on the performance in swine fattening. Zeitschrift für Tierphysiologie, Tierernährung und Futtermittelkunde, 36, 241248.
  • Tranquilli, W.J., Parks, C.M., Thurmon, J.C., Benson, G.J., Koritz, G.D., Manohar, M. & Theodorakis, M.C. (1982) Organ blood flow and distribution of cardiac output in nonanesthetized swine. American journal of veterinary research, 43, 895897.
  • United States Environmental Protection Agency (US-EPA). (2001) Process for conducting probabilistic risk assessment. APPENDIX B: selection and fitting of distributions.
  • United States Food and Drug Administration (US-FDA). (1992) Statistical procedures for bioequivalence studies using a standard two treatment cross-over design.
  • Upton, R.N. (2008) Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling. Journal of pharmacological and toxicological methods, 58, 198205.
  • Voogd, C.E., van der Stel, J.J. & Jacobs, J.J. (1980) The mutagenic action of quindoxin, carbadox, olaquindox and some other N-oxides on bacteria and yeast. Mutation research, 78, 233242.
  • Williams, B.J. & Shively, J.E. (1978) In vitro antitreponemal activities of carbadox, virginiamycin, olaquindox, and tylosin as indices of their effectiveness for preventing swine dysentery. Veterinary medicine, small animal clinician, 73, 349351.
  • Wu, Y.J., Yu, H., Wang, Y.L., Huang, L.L., Tao, Y.F., Chen, D.M. & Yuan, Z.H. (2007) Development of a high-performance liquid chromatography method for the simultaneous quantification of quinoxaline-2-carboxylic acid and methyl-3-quinoxaline-2-carboxylic acid in animal tissues. Journal of Chromatography A., 1146, 17.
  • Yang, B., Huang, L.L., Wang, Y.L., Liu, Y., Tao, Y.F., Chen, D.M., Liu, Z.L., Fang, K., Chen, Y.P. & Yuan, Z.H. (2010) Residue depletion and tissue-plasma correlation of methyl-3-quinoxaline-2-carboxylic acid after dietary administration of olaquindox in pigs. Journal of Agricultural and Food Chemistry, 58, 937942.
  • Yoshimura, H., Nakamura, M., Koeda, T. & Yoshikawa, K. (1981) Mutagenicities of carbadox and olaquindox–growth promoters for pigs. Mutation research, 90, 4955.
  • Zou, J., Chen, Q., Tang, S., Jin, X., Chen, K., Zhang, T. & Xiao, X. (2009) Olaquindox-induced genotoxicity and oxidative DNA damage in human hepatoma G2 (HepG2) cells. Mutation research, 676, 2733.